COM:TCR2
Adaptimmune
- Stock
Last Close
1.48
31/05 20:00
Market Cap
58.11M
Beta: -
Volume Today
3.75M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|
net income | -9.91M - | -13.07M 31.82% | -24.25M 85.55% | -47.60M 96.28% | -67.12M 41.02% | -99.81M 48.69% | -151.82M 52.12% | |
depreciation and amortization | 220K - | 298K 35.45% | 419K 40.60% | 862K 105.73% | 1.59M 84.69% | 2.83M 77.58% | 3.05M 7.75% | |
deferred income tax | 131K - | 99K 24.43% | -293K 395.96% | |||||
stock based compensation | 93K - | 408K 338.71% | 2.13M 422.79% | 6.70M 214.21% | 8.49M 26.71% | 12.27M 44.43% | 11.38M 7.22% | |
change in working capital | 222K - | 329K 48.20% | 3.20M 872.34% | -1.10M 134.35% | 872K 179.34% | 1.62M 85.44% | 9.58M 492.46% | |
accounts receivables | ||||||||
inventory | ||||||||
accounts payables | 76K - | -101K 232.89% | 2.22M 2,301.98% | -179K 108.05% | 451K 351.96% | -771K 270.95% | 1.17M 251.23% | |
other working capital | 146K - | 430K 194.52% | 975K 126.74% | -920K 194.36% | 421K 145.76% | 2.39M 467.22% | 8.41M 252.35% | |
other non cash items | -1K - | -278K 27,700% | -225K 19.06% | -702K 212% | 1.40M 298.86% | 26.65M 1,808.88% | ||
net cash provided by operating activities | -9.38M - | -12.04M 28.32% | -18.78M 56.02% | -41.36M 120.25% | -56.74M 37.19% | -81.60M 43.82% | -101.46M 24.33% | |
investments in property plant and equipment | -869K - | -388K 55.35% | -1.02M 162.63% | -3.88M 280.67% | -7.16M 84.69% | -11.45M 59.81% | -15.45M 34.96% | |
acquisitions net | 1.03M - | 4.15M 301.65% | 7.78M 87.39% | 351K 95.49% | 15.45M 4,302.28% | |||
purchases of investments | -8.35M - | -6.48M 22.40% | -97.81M 1,409.41% | -126.26M 29.09% | -152.81M 21.03% | -50.73M 66.80% | -267.52M 427.39% | |
sales maturities of investments | 14.83M - | 22.49M 51.65% | 109.72M 387.88% | 111.04M 1.20% | 140.62M 26.64% | 194.49M 38.31% | ||
other investing activites | -290K - | -1.03M 256.21% | -4.15M 301.65% | -7.78M 87.39% | -351K 95.49% | -15.45M 4,302.28% | ||
net cash used for investing activites | -9.22M - | 7.67M 183.22% | -76.34M 1,095.03% | -20.41M 73.26% | -48.94M 139.70% | 78.45M 260.31% | -88.49M 212.80% | |
debt repayment | ||||||||
common stock issued | 125M - | 79.13M 36.69% | 133.57M 68.80% | 131.33M 1.68% | 256K 99.81% | |||
common stock repurchased | ||||||||
dividends paid | ||||||||
other financing activites | 22.49M - | 16.18M 28.03% | -2.02M 112.48% | 391K 119.36% | 1.13M 188.49% | 808K 28.37% | -131K 116.21% | |
net cash used provided by financing activities | 22.49M - | 16.18M 28.03% | 122.98M 659.93% | 79.52M 35.34% | 134.70M 69.38% | 132.14M 1.90% | 125K 99.91% | |
effect of forex changes on cash | ||||||||
net change in cash | 3.89M - | 11.82M 204.06% | 27.86M 135.75% | 17.75M 36.30% | 29.02M 63.53% | 128.98M 344.38% | -189.82M 247.17% | |
cash at beginning of period | 4.11M - | 7.99M 94.69% | 19.81M 147.89% | 47.96M 142.11% | 65.71M 37.00% | 94.74M 44.17% | 223.72M 136.15% | |
cash at end of period | 7.99M - | 19.81M 147.89% | 47.67M 140.64% | 65.71M 37.84% | 94.74M 44.17% | 223.72M 136.15% | 33.90M 84.85% | |
operating cash flow | -9.38M - | -12.04M 28.32% | -18.78M 56.02% | -41.36M 120.25% | -56.74M 37.19% | -81.60M 43.82% | -101.46M 24.33% | |
capital expenditure | -869K - | -388K 55.35% | -1.02M 162.63% | -3.88M 280.67% | -7.16M 84.69% | -11.45M 59.81% | -15.45M 34.96% | |
free cash flow | -10.25M - | -12.42M 21.22% | -19.80M 59.34% | -45.24M 128.51% | -63.90M 41.26% | -93.05M 45.61% | -116.91M 25.64% |
All numbers in (except ratios and percentages)